Literature DB >> 1141286

Hypoxaemia after fractures.

S S Tachakra, S Sevitt.   

Abstract

Serial arterial blood-gas analyses showed a phase of primary hypoxaemia in thirty-two out of fifty fracture patients (64 per cent) without head, chest or abdominal injury. The incidence was greater in those with shaft fractures of the femur or tibia or both, than in those with fractured hips, and was related to the severity of injury and the nature of the accident. Most affected subjects were already hypoxaemic on admission to hospital; the arterial PO2 commonly fell to between 60 and 70 millimetres of mercury, and the episode generally lasted a few days. The hypoxaemia was generally subclinical but four patients developed mild fat embolism. Early hypoxaemia was not found in six patients admitted with only soft-tissue injuries. One or more subsequent attacks of subclinical hypoxaemica, each lasting a few days, occurred in half of those previously affected. Most episodes followed fracture operation or manipulation. Pulmonary thromboembolism seemed responsible in two patients, but it could be excluded in others given oral anticoagulant prophylaxis from soon after admission. Pulmonary fat embolism is the most likely explanation of the primary episodes and could account for most of the subsequent periods of hypoxaemia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1141286

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  3 in total

Review 1.  Orthopaedic management in the polytrauma patient.

Authors:  Jason J Halvorson; Holly T-P Pilson; Eben A Carroll; Zhongyu John Li
Journal:  Front Med       Date:  2012-09-07       Impact factor: 4.592

2.  Preventing fat embolism.

Authors: 
Journal:  Br Med J       Date:  1978-05-13

3.  A Lethal Case of Fat Embolism Syndrome in a Nine-Year-Old Child: Options for Prevention.

Authors:  Pascal H E Teeuwen; Pim C E J Sloots; Ivo de Blaauw; Rene Wijnen; Jan Biert
Journal:  Eur J Trauma Emerg Surg       Date:  2008-11-26       Impact factor: 3.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.